Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens

Journal of Neuroscience Research

Volumn 51, Issue 5, 1998, Pages 583-592

  Mathé, Jan M ^a   Nomikos, George G ^a   Schilström, Björn ^a   Svensson, Torgny H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CNQX; Dopamine; Locomotion; MK 801; Ventral tegmental area

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMINO ACID RECEPTOR BLOCKING AGENT; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DIMETHYL SULFOXIDE; DIZOCILPINE; DOPAMINE; DRUG VEHICLE; EXCITATORY AMINO ACID RECEPTOR; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; NEUROLEPTIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

3,4-DIHYDROXYPHENYLACETIC ACID; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; HOMOVANILLIC ACID; LOCOMOTION; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, INBRED STRAINS; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; VENTRAL TEGMENTAL AREA;

EID: 0032032540     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980301)51:5<583::AID-JNR5>3.0.CO;2-B     Document Type: Article

References (46)

1. Bubser M, Tzschentke T, Hauber W (1995): Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats. J Neural Transm 101:115-126.
2. 10 dopamine neurons is differentially affected by lesions of the nucleus accumbens and medial prefrontal cortex. Life Sci 45:637-646.
3. Chergui K, Charléty PJ , Akaoka H, Saunier CF, Brunet JL, Buda M, Svensson TH, Chouvet G (1993): Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur J Neurosci 5:137-144.
4. Clineschmidt BV, Martin GE, Bunting PR, Papp NL (1982): Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev Res 2:135-145.
5. Contreras PC, Monahan JB, Lanthorn TH, Pullan LM, DiMaggio DA, Handelmann GE, Gray NM, O'Donohue TL (1987): Phencyclidine: Physiological actions, interactions with excitatory amino acids and endogenous ligands. Mol Neurobiol 1:191-211.
6. Criswell HE, Johnson KB, Mueller RA, Breese GR (1993): Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. J Pharmacol Exp Ther 265:1001-1010.
7. Deutch AY, Clark WA, Roth RH (1990): Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neruons to stress. Brain Res 521:311-315.
8. Fessler RG, Sturgeon RD, Meltzer HY (1980): Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats. Pharmacol Biochem Behav 13:835-842.
9. French ED (1986): Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat. Neuropharmacology 25:241-248.
10. Freeman AS, Bunney BS (1984): The effects of phencyclidine and n-allylnormetazocine on midbrain dopamine neuronal activity. Eur J Pharmacol 104:287-293.
11. Grace AA, Bunney BS (1980): Effects of baclofen on nigral dopaminergic cell activity following acute and chronic haloperidol treatment. Brain Res Bull 5:537-543.
12. Grace AA, Bunney BS (1984): The control of the firing pattern in nigral dopamine neurons: Burst firing. J Neurosci 4:2877-2890.
13. Jaskiw GE, Karoum F, Freed WJ, Phillips I, Kleinman JE, Weinberger DR (1990): Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat. Brain Res 534:263-272.
14. Javitt DC, Zukin SR (1991): Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
15. Kalivas PW, Duffy P, Barrow J (1989): Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 251:378-387.
16. Kornhuber JM, Weller M (1995): Predicting psychotomimetic properties of PCP-like NMDA receptor antagonists, In R. Fog, J.Gerlach, R. Hemmingsen (eds): "Schizophrenia, Alfred Benzon Symposium." Copenhagen: Munksgaard 38:314-325.
17. Liu J, Moghaddam B (1995): Regulation of glutamate efflux by excitatory amino acid receptors: Evidence for tonic inhibitory and phasic excitatory regulation. J Pharmacol Exp Ther 274: 1209-1215.
18. Löscher WR, Hönack D (1992): The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur J Pharmacol 215:199-208.
19. Marshall DL, Redfern PH, Wonnacott S (1997): Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats. J Neurochem 68:1511-1519.
20. Mathé JM, Nomikos GG, Hildebrand BE, Hertel P, Svensson TH (1996a): Prazosin inhibits MK-801 induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur J Pharmacol 309:1-11.
21. Mathé JM, Schilström B, Nomikos GG, Svensson TH (1996b): Non-NMDA receptors in the ventral tegmental area mediate hyperlocomotion and dopamine release in the n. accumbens induced by systemic MK-801. (Abstract) Proceedings of the Eighth International Catecholamine Symposium, Pacific Grove, CA, USA.
22. Mercuri NB, Grillner P, Bernardi G (1996): N-methyl-d-aspartate receptors mediate a slow excitatory postsynaptic potential in the rat midbrain dopaminergic neurons. Neuroscience 74:785-792.
23. Miller DW, Abercrombie ED (1996): Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats. Brain Res Bull 40:57-62.
24. Moghaddam B, Adams B, Verma A, Daly D (1997): Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927.
25. Murase S, Mathé JM, Grenhoff J, Svensson TH (1993): Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: Differential actions related to anatomical localization. J Neural Transm (Gen Sect) 91:13-25.
26. Narayanan S, Willins D, Dalia A, Wallace L,. Urtesky NJ (1996): Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens. Pharmacol Biochem Behav 54:565-573.
27. Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1989): Acute effects of buproprion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology 2:273-279.
28. Nomikos GG, Iurlo M, Andersson JL, Kimura K, Svensson TH (1994): Systemic administration of amperozide,. a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology 115:147-156.
29. Pawlowski L, Mathé JM, Svensson TH (1990): Phencyclidine activates rat A10 dopamine neurons but reduces burst activity and causes regularization. Acta Physiol Scand 139:529-530.
30. Paxinos G, Watson C (1986): "The Rat Brain in Stereotaxic Coordinates," 2nd Ed. London: Academic Press.
31. Rouillard C, Chiodo LA, Freeman AS (1990): The effects of the phencyclidine analogs BTCP and TCP on nigrostriatal dopamine neuronal activity. Eur J Pharmacol 182:227-235.
32. Scarnati E, Pacitti C (1982): Neuronal responses to iontophoretically applied dopamine, glutamate and GABA of identified dopaminergic cells in the rat substantia nigra after kainate acid-induced destruction of the striatum. Exp Brain Res 46:377-382.
33. Schilström B, Nomikos GG, Nisell M, Hertel P, Svensson TH (1998): NMDA receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 82:781-789.
34. Seutin V, Johnsson SW, North RA (1994): Effect of dopamine and baclofen on n-methyl-d-aspartate-induced burst firing in rat ventral tegmental neurons. Neuroscience 58:201-206.
35. Svensson TH, Mathé JM, Nomikos GG, Schilström B, Marcus M, Fagerquist M (1997): Interactions between catecholamines and serotonin: relevance to the pharmacology of schizophrenia. In DS Goldstein, G Eisenhofer, R McCarty (Eds.) "Advances in Pharmacology." Academic Press, pp. 814-818.
36. Timmerman W, Westerink BHC (1997): Brain microdialysis of GABA and glutamate: What does it signify?. Synapse 27:242-261.
37. Toth E, Sershen H, Hashim A, Vizi ES, Lajtha A (1992): Effects of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo. Neuropharmacology 32:827-832.
38. Ungerstedt U (1971): Stiatal dopamine release after amphetamine or nerve degeneration revealed by rotational behavior. Acta Physiol Scand 82:49-68.
39. 1 receptors. Brain Res 622:325-329.
40. Westerink BHC, Justice JB (1991): Microdialysis compared with other in vivo release models, In: Robinson TE, Justice JB (eds): "Microdialysis in the Neurosciences." Elsevier Science Publishers B.V., pp. 23-43.
41. Westerink BHC (1995): Brain microdialyis and its application for the study of animal behaviour. Behav Brain Res 70:103-124.
42. Willins DL, Nayaranan S, Wallace LJ, Uretsky NJ (1993): The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK-801. Pharmacol Biochem Behav 46:881-887.
43. Wolf ME, White FJ, Hu XT (1993): Behavioral sensitization to MK-801 (dizocilpine): Neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. Behav Pharmacol 4:429-442.
44. Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986): The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83:7104-7108.
45. Zhang J, Chiodo LA, Freeman AS (1992): Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res 590:153-163.
46. Zhang J, Chiodo LA, Freeman AS (1993): Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl)guanidine on non-dopaminergic midbrain neurons. Eur J Pharmacol 230:371-374.